Managing innovation in the pharmaceutical industry

Journal of Commercial Biotechnology

Volumn 12, Issue 1, 2005, Pages 50-57

  Schmid, Esther F ^a   Smith, Dennis A ^b  

^a PGRD   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Innovation; Management; Pharmaceutical industry

Indexed keywords

COSTS; DECISION MAKING; DRUG PRODUCTS; INDUSTRY; RISK MANAGEMENT; STRATEGIC PLANNING;

FOOD AND DRUG ADMINISTRATION (CO); INNOVATION; PHARMACEUTICAL INDUSTRY; TIME COURSE ANALYSIS;

RESEARCH AND DEVELOPMENT MANAGEMENT;

ARTICLE; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; COST BENEFIT ANALYSIS; DECISION MAKING; DRUG INDUSTRY; HEALTH CARE ORGANIZATION; RISK MANAGEMENT;

EID: 29444452280     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040148     Document Type: Article

References (9)

1. Mackenzie-Lawrie, S. (2003), 'Innovation, efficiency and outsourcing', Scrip Magazine, May.
2. URL: http://www.wallstreetwinners.net/invite/index.asp?promo=W10942/
3. Drews, J. (2003), 'Strategic trends in the drug industry', Drug Discovery Today, Vol. 8(9), pp. 411-420.
4. Schmid, E. F. and Smith, D. A. (2005), 'Is declining innovation in the pharmaceutical industry a myth?', Drug Discov. Today (in press).
5. URL: http://www.dnalc.org/bioinformatics/2003/gleevec_3.htm
6. De-Silva, E. and Stumpf, P. M. (2004), 'HIV and the CCR5-delta 32 resistance allele', FEMS Microbiol. Lett., Vol. 241 (1), pp. 1-12.
7. Hopkins, A. (2002), 'The druggable genome', Nature Rev. Drug Discovery, Vol. 1(9) pp. 727-730.
8. Stacy, R. (1996), 'Complexity and Creativity in Organisations', Brett-Koehler, San Francisco, CA.
9. Henry, J. (2002), 'Creativity and Perception in Management', Open University, Milton Keynes.